Effects of single and combined immunotherapy approach targeting amyloid β protein and α-synuclein in a dementia with Lewy bodies-like model-Reference-Cited by-同舟云学术

Effects of single and combined immunotherapy approach targeting amyloid β protein and α-synuclein in a dementia with Lewy bodies-like model

Published:2019-08-01 Issue:9 Volume:15 Page:1133-1148
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Mandler Markus¹,Rockenstein Edward²,Overk Cassia²,Mante Michael²,Florio Jazmin²,Adame Anthony²,Kim Changyoun³,Santic Radmila¹,Schneeberger Achim¹,Mattner Frank¹,Schmidhuber Sabine¹,Galabova Gergana¹,Spencer Brian²,Masliah Eliezer²³⁴,Rissman Robert A.²⁵

Affiliation:

1. AFFiRiS AG; Vienna Biocenter; Vienna Austria

2. Department of Neurosciences; University of California; San Diego La Jolla CA USA

3. Division of Neuroscience and Laboratory of Neurogenetics; National Institute on Aging; NIH; Bethesda MD USA

4. Department of Pathology; University of California; San Diego La Jolla CA USA

5. VA San Diego Healthcare System; La Jolla CA USA

Funder

NIH

AFFiRiS

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Clinical Neurology,Developmental Neuroscience,Health Policy,Epidemiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1016/j.jalz.2019.02.002/fullpdf

Reference99 articles.

1. Parkinson's disease dementia: convergence of alpha-synuclein, tau and amyloid-beta pathologies;Irwin;Nat Rev Neurosci,2013

2. Interactions of pathological proteins in neurodegenerative diseases;Spires-Jones;Acta Neuropathol,2017

3. The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity;Hansen;Neurology,1990

4. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop;McKeith;J Alzheimers Dis,2006

5. DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers;Lippa;Neurology,2007

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug development targeting degeneration of the basal forebrain cholinergic system: its time has come;Molecular Neurodegeneration;2023-10-04

2. Nicotine-mediated effects in neuronal and mouse models of synucleinopathy;Frontiers in Neuroscience;2023-08-31

3. Noninfectious Disease Vaccines;Plotkin's Vaccines;2023

4. Preclinical and randomized clinical evaluation of the p38α kinase inhibitor neflamapimod for basal forebrain cholinergic degeneration;Nature Communications;2022-09-21

5. A Novel C-Type Lectin Receptor-Targeted α-Synuclein-Based Parkinson Vaccine Induces Potent Immune Responses and Therapeutic Efficacy in Mice;Vaccines;2022-08-30